Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal
Go back to Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal| Alpine Management Systems, Inc. (NASDAQ: ALPN) | Delayed: 64.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.97 | 52 Week High | $0.00 | |||
| Open | $43.88 | 52 Week Low | $2156.81 | |||
| Day High | $64.97 | P/E | N/A | |||
| Day Low | $64.97 | EPS | $0.00 | |||
| Volume | 6,065 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 451.63 -7.36 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $458.99 | 52 Week High | $134.71 | |||
| Open | $462.17 | 52 Week Low | $73.31 | |||
| Day High | $464.98 | P/E | N/A | |||
| Day Low | $450.39 | EPS | $-1.98 | |||
| Volume | 2,993,024 | |||||
